Trial Profile
A comparative, randomized study to evaluate the effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Metoprolol (Primary) ; Nebivolol (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 15 Sep 2015 New trial record